Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
Heparan sulfate (HS) is a glycosaminoglycan present on all animal cell surfaces and directly interact with myriad extracellular signaling molecules. HS is required for embryonic development and for the functioning of every adult physiological system. The interactions between many families of growth factors and growth factor receptors are modulated depending on the structures of HS expressed on cell surfaces and extracellular matrices. Thus, it is not surprising that understanding of HS structural biochemistry is central to understanding of disease mechanisms including tumor growth, angiogenesis, amyloid deposition, tissue remodeling and repair, and host-pathogen interactions.
Two approaches commonly used to compare mass spectral data are clustering analysis and principal components analysis. Cluster analysis consists of dividing data into groups (clusters) in order to capture the natural structure of the data. One of the first references of clustering in the mass spectrometry field was used to compared alkyl thiolesters and pharmaceutical products. Clustering analysis of tandem MS data was applied in the proteomics field for the following purposes : (1) to reduce the number of tandem mass spectra used in the identification of proteins by regrouping similar tandem data to decrease the redundancies of the analyses; (2) to improve the understanding of fragmentation patterns (fragmentation vs intensity) to enable improved protein identification algorithms; and (3) to facilitate label free quantification experiments for the discovery of biomarkers.
We have developed a novel fully automated approach based on the new interpretation of tandem MS data of HS oligosaccharides extracted from different organ tissues. We applied this approach to a set of data acquired using a automated collisionally activated dissociation (CAD) tandem MS acquisition parameters. Tandem mass spectrometry of 12 targeted precursor ions were acquired on HS oligosaccharides extracted from each of four bovine tissues (aorta, lung, intestine and kidney) acquired automatically in triplicate was the fundaments of the study. The size of the corresponding data set was approximately 2800 features, for which manual comparison was not feasible. We used agglomerative hierarchical clustering (AHC) on the tandem MS data to demonstrate that sufficient information for differentiation of isomeric glycoforms in the four organs samples was present. The analysis was useful for recognition of fragmentation patterns corresponds to organ-specific HS structures.
Public Health Relevance Statement
Data not available.
NIH Spending Category
Biotechnology
Project Terms
AdultAlgorithmsAmyloid depositionAnimalsAortaBiological MarkersBiologyCattleCell surfaceCluster AnalysisDataData SetDiseaseDissociationEmbryonic DevelopmentExtracellular MatrixFamilyFundingGlycosaminoglycansGrantGrowth FactorGrowth Factor ReceptorsHeparitin SulfateIntestinesIonsKidneyLabelLungManualsMass Spectrum AnalysisMedicineNational Center for Research ResourcesOligosaccharidesOrganPatternPharmacologic SubstancePhysiologicalPrincipal Component AnalysisPrincipal InvestigatorProteinsProteomicsResearchResearch InfrastructureResourcesSamplingSignaling MoleculeSourceStructural BiochemistryStructureSystemTissuesUnited States National Institutes of Healthangiogenesisbasecostextracellularimprovednovelpathogenrepairedresearch studytandem mass spectrometrytumor growth
No Sub Projects information available for 5P41RR010888-15 5082
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P41RR010888-15 5082
Patents
No Patents information available for 5P41RR010888-15 5082
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P41RR010888-15 5082
Clinical Studies
No Clinical Studies information available for 5P41RR010888-15 5082
News and More
Related News Releases
No news release information available for 5P41RR010888-15 5082
History
No Historical information available for 5P41RR010888-15 5082
Similar Projects
No Similar Projects information available for 5P41RR010888-15 5082